Articles tagged with Chronic Inflammation
A new implantable device, inspired by a tree branch, uses DNA sensors to continuously monitor inflammation biomarkers in the body. The device accurately measures protein biomarkers of inflammation in diabetic rats and has potential applications for managing acute and chronic conditions.
A recent study by Krishna Rao Maddipati suggests that chronic inflammation has a distinct etiology, differing from acute inflammation. The study proposes increasing anti-inflammatory compounds to treat chronic inflammation, potentially leading to new advancements in cancer therapy.
Researchers are conducting a multi-year study to understand small airway abnormalities and their role in emphysema development. The SPIROMICS Study of Early Disease Progression (SOURCE) aims to provide novel insights into COPD progression and inform the development of new therapies.
A multicenter national clinical trial is being conducted to study whether giving antibiotics at the start of labor induction can decrease C-sections in pregnant women with obesity. The trial aims to enroll nearly 800 women and analyze infection rates, complications, and microbiome changes.
A new study suggests that immune system imbalances may trigger and sustain depressive symptoms, particularly in high-risk groups. The review challenges traditional neurotransmitter-focused theories and offers insights into the complex interactions between inflammation and depressive symptoms.
A team of researchers, including Binghamton University's Ahyeon Koh, is working on an innovative project to treat inflammatory bowel diseases like Crohn's and ulcerative colitis. The goal is to create a 'cell factory' in the body that can produce pharmaceuticals to alleviate symptoms.
Researchers mapped how HSV-1 enters the brain, infects critical regions, and triggers neurological diseases. The virus was found in areas controlling vital functions, such as sleep and movement, and interacted with immune cells that led to chronic inflammation.
Researchers found elevated levels of cytokines in the blood of long COVID patients, which could explain cardiovascular symptoms. The study also showed that these trace-level cytokines had a direct effect on cardiomyocytes, the heart's pumping cells.
Researchers propose a comprehensive biomarker-based approach to assess cardiovascular risk by combining markers of chronic inflammation with cardiac health indicators. This approach reveals the significant impact of aging-related inflammation, or 'inflammaging,' on heart health and opens new avenues for targeted interventions.
Researchers developed an in vitro model of murine peritoneal macrophage aging to study molecular mechanisms and develop innovative strategies. Chronic treatment with CB3 completely prevented the increase of p21CIP1 and maintained proliferative activity in day 14 macrophages.
Researchers investigate how liver necroptosis triggers inflammation in both organs, leading to cognitive impairment. Studying aging mouse models, they found that liver necroptosis causes systemic inflammation affecting brain function.
A new study found that children diagnosed with IBD before the age of six show biological changes associated with the disease at birth. This suggests that these children are part of a severely affected subgroup, making preventive options crucial for their investigation. The study's findings could lead to earlier screening and potentiall...
Researchers at TUM found that mitochondrial dysfunction in mice leads to chronic intestinal inflammation and changes in the gut microbiome. The study suggests potential new treatments targeting mitochondrial pathways or addressing the connections between the microbiome and mitochondria.
A new study found that nearly six in ten Americans have pro-inflammatory diets, increasing the risk of health problems like heart disease and cancer. Anti-inflammatory foods such as garlic, ginger, and turmeric can help combat chronic conditions like diabetes and depression.
Researchers found that fever temperatures increase helper T cell metabolism, proliferation and inflammatory activity, while causing mitochondrial stress, DNA damage and cell death in a specific subset of Th1 cells. These findings may explain how chronic inflammation contributes to cancer development and suggest a fundamental way cells ...
Associate Professor Justine Tigno-Aranjuez received a $1 million NSF CAREER Award to study the impact of the NOD2 pathway on inflammation. Her research aims to understand how lipid mediators are produced and how they influence inflammation.
A pioneering £4.8m eight-year programme will harness artificial intelligence to investigate the link between nutrition, health inequality and the development of multiple long-term conditions. The InflAIM project aims to identify new ways to slow the progression of multiple long-term health problems in people most at risk.
A new study found that cystic fibrosis patients with more severe disease characteristics exhibit shorter leukocyte telomere length and greater LTL attrition. This association may accelerate aging and increase susceptibility to age-related diseases, emphasizing the importance of early CF diagnosis and timely therapeutic intervention.
Researchers have identified key cellular interactions and microenvironments that contribute to the development of chronic kidney disease (CKD) after acute kidney injury (AKI) in mice. The study, published in Nature Communications, provides new insights into how damaged cells interact within disease-promoting microenvironments.
The UofL Green Heart Louisville Project found that residents living in neighborhoods with more trees showed lower levels of general inflammation, a risk indicator for heart disease. The study showed a 13-20% reduction in inflammation, corresponding to a nearly 10-15% reduced risk of heart attacks and certain cancers.
Researchers found that administering PEPITEM to older mice reduced exaggerated immune responses, indicating a potential geroprotective agent. The study also revealed an age-related decline in the PEPITEM pathway, which could be rescued by the peptide.
Researchers found that the frequency of activated TREG cells remained elevated during treatment and continued to be high even after the virus was eliminated. Inflammatory features, such as increased TNF signaling, were sustained in TREG cells, indicating long-term immune system changes induced by the chronic infection.
A study found that higher levels of inflammation in early adulthood may negatively affect cognitive skills like planning, focus and processing information in middle age. Those with consistently high or moderate inflammation had poorer performance in processing speed and executive function.
Scientists at Brigham and Women's Hospital have identified a metabolic switch in the gut that helps regulate immune tolerance and protect against harmful intestinal inflammation. This discovery could lead to new strategies for promoting remission in patients with inflammatory bowel disease.
Researchers found that aged mouse gut microbes increase inflammation in young mice, suggesting a link between microbiome changes and aging-induced inflammatory processes.
Researchers at Bielefeld University discovered that certain gluten-derived molecules, including the 33-mer deamidated gliadin peptide (DGP), form nanosized structures that accumulate in gut epithelial cells and lead to leaky gut syndrome. This triggers chronic inflammation and autoimmune responses in celiac disease patients.
A study published by Cornell University researchers found that more frequent positive contact with nature is associated with reduced inflammation levels. The study, which analyzed data from the Midlife in the U.S. survey, suggests that enjoying nature can help prevent or manage diseases linked to chronic inflammation.
A new hypothesis suggests that chronic inflammation is spreading among people at unprecedented rates, affecting cognitive ability to address critical issues. The authors propose a mechanism where the brain creates its own copy of bodily inflammation, leading to impaired cognition, emotion, and behavior.
Research reveals that physical inactivity and chronic inflammation drive secondary aging, altering gene expression in skeletal muscle. The study identified approximately 4,000 genes affected by physical inactivity and inflammation, while fewer than 200 were linked to primary aging.
Research from the German Cancer Research Center reveals that repetitive changes in female reproductive organs over time lead to chronic inflammation and fibrosis, which may contribute to increased uterine cancer risk. The study mapped the effects of estrous cycle, pregnancy, and aging on the reproductive tract.
Researchers discovered that fasting raises arachidonic acid levels, which inhibit the NLRP3 inflammasome and reduce chronic inflammation. This finding may explain how calorie restriction protects against diseases linked to Western diets.
Researchers at University of Tsukuba discovered a correlation between hypoxia levels and clinical symptoms in UC patients. Lower oxygen saturation in the rectal mucosa was associated with greater severity of colitis, making this method a potential tool for objective measurement of disease activity.
A new exhalation delivery system using fluticasone directly targets the sinuses, reducing symptoms and inflammation in patients with chronic rhinosinusitis. The system showed significant improvements compared to a placebo, providing hope for non-invasive treatment options.
Researchers have shown that combining poverty with chronic inflammation worsens health outcomes, increasing heart disease and cancer mortality rates. The study analyzed data from nearly 95 million adults and found a synergistic effect of poverty and inflammation on mortality.
A new study by University of Florida researcher Arch Mainous III found that people with chronic inflammation living in poverty have a significantly increased risk of dying from heart disease (127% increase) and cancer (196% increase) within 15 years. The study analyzed data from over 95 million Americans ages 40 and over, highlighting ...
A post-hoc analysis of the CANTOS trial found no effect of canakinumab on frailty incidence or self-reported function. The study suggests that inflammation may not be a causal factor in the development of frailty in these participants.
A multicenter, retrospective study of Japanese patients treated with JAK inhibitors found impressive remission rates and low disease activity. The study's results contradict previous concerns about the effectiveness of these drugs, suggesting they may be a viable option for patients with other health problems.
A recent study found a compelling link between vitamin B12 deficiency and chronic inflammation, which can lead to various health problems. The research revealed an inverse relationship between vitamin B12 levels and inflammatory markers in humans and mice, suggesting that higher vitamin B12 levels may lower inflammatory markers.
Researchers found persistent inflammation in intestines of patients 20 years post-radiotherapy, even with targeted treatments. This could lead to chronic symptoms like tenesmus and frequent diarrhea.
Researchers at the University of Virginia Health System discovered that improper calcium signaling in mitochondria accelerates chronic inflammation, leading to age-related conditions. Increasing calcium uptake in macrophages may help prevent harmful inflammation and its effects on the brain.
Pharmaceutical scientists from the National University of Singapore have developed multi-functional synthetic peptide nanonets for relieving inflammation caused by bacterial infection. These nanonets trap bacterial endotoxins and pro-inflammatory cytokines, achieving anti-inflammatory activity through selective binding.
Researchers found that apoE4 poorly binds factor H, a regulatory factor of immunity, leading to amyloid-β oligomerization and neuroinflammation. This could be a potential solution to preventing Alzheimer's disease, with further research needed to find a bridging molecule.
Scientists discovered that inhibiting microRNA-141-3p can reduce chronic inflammation, muscle loss, and bone degradation in aged mice. By blocking this tiny RNA, researchers found improvements in the spleen's immune response, lower levels of pro-inflammatory proteins, and a more youthful profile in bones and muscles.
New research suggests a way to ward off age-related weight gain by stimulating beige fat cells. Beige fat has thermogenic properties that can reduce blood sugar and fatty acids causing heart disease. The study identifies a specific signaling pathway responsible for suppressing beige fat formation in older mice.
Human macrophages use Siglec-14 receptors to recognize and engulf carbon nanotubes, leading to inflammation. The discovery could pave the way for developing safer carbon nanotubes and therapies to prevent inflammatory diseases.
A recent study found that resistance training significantly improved muscle strength and reduced inflammation in older adults with sarcopenia. The research, conducted by Brazilian researchers, also showed that physical exercise can improve sleep quality and reduce chronic inflammation.
Researchers at the University of Virginia Health System have identified a vital contributor to hyperactive immune responses and neuroinflammation in multiple sclerosis. Blocking this regulator alleviated harmful inflammation in lab mice, suggesting a potential therapeutic target for new treatments.
Research suggests that avoiding or withdrawing from tough conversations can lead to emotional distress, bad feelings about the relationship, chronic inflammation, and lowered immune function. Couples who exhibit negative communication patterns report fewer positive emotions and slower wound healing.
Researchers have discovered a pathway in cells that could be used to reprogram the body's immune system to fight chronic inflammatory and infectious diseases. A molecule derived from glucose, ribulose-5-phosphate, has been found to stop bacteria from growing and dampen inflammatory responses.
A new study found that chronic inflammation in lactating mothers with obesity may contribute to low milk production. The researchers analyzed fatty acid and inflammatory marker profiles in blood and breast milk, finding a strong correlation between the two in non-obese mothers but not in those with chronic inflammation.
Researchers at UVA Cancer Center have identified interleukin-1 as a crucial contributor to the development of myelofibrosis, a potentially deadly bone marrow cancer. Targeting this cytokine could prevent myelofibrosis from progressing and spare bone marrow scarring.
A new study suggests that lifestyle choices can help prevent severe COVID-19 by reducing chronic inflammation and regulating the immune system. By adopting healthy habits such as regular exercise, balanced diet, and stress management, individuals can lower their risk of developing severe disease and mitigate post-infection symptoms.
A large randomized clinical trial demonstrated Octagam 10% as an efficacious and well-tolerated treatment option for adult dermatomyositis patients. The study showed improved outcomes in patients with this rare disease, providing a much-needed treatment alternative.
Researchers are studying the interaction between obesity and nitric oxide synthase in triple-negative breast cancer, aiming to develop a new treatment strategy. Another team is investigating the role of NHE6 protein in multiple myeloma resistance to daratumumab treatment, with the goal of improving therapy outcomes for patients.
A study at Washington State University has identified sulfatase-2 as a critical protein driving damage caused by rheumatoid arthritis. The discovery sheds light on molecular processes behind inflammation in the disease and could lead to improved treatments.
A study published in Frontiers in Immunology found that Japanese herbal medicine DKT reduces colitis severity by preventing gut bacteria loss and increasing immune cells. It restores Lactobacillus levels and promotes type 3 innate lymphoid cells, alleviating inflammatory responses.
A world-first study reveals a direct link between low vitamin D and high inflammation, providing a biomarker for those at risk of chronic illnesses. Boosting vitamin D in people with deficiencies may reduce chronic inflammation.
A team from Osaka University developed a silicon-based agent that generates hydrogen when reacting with water, reducing inflammation and symptoms of ulcerative colitis in a mouse model. The study suggests the Si-based agent may be an effective treatment method for this disease.
Researchers developed an AI system that classifies IBDN lesions accurately, displaying image-based diagnostic ability with 64.5% sensitivity and 89.5% specificity. The correct diagnosis rate of the AI system was 79.0, surpassing that of endoscopists, who achieved a 77.8% accuracy rate.
Researchers at Joslin Diabetes Center and Brigham and Women's Hospital found that cold exposure can resolve obesity-induced inflammation while improving insulin sensitivity and glucose tolerance in diet-induced obese mice. Brown adipose tissue is activated to produce anti-inflammatory molecules, including Maresin 2.